PreOmics is a cutting-edge startup specializing in the preparation of peptide and protein samples for Liquid Chromatography-Mass Spectrometry (LC-MS) analysis. The company operates in the proteomics market, which involves the large-scale study of proteins, particularly their structures and functions. PreOmics provides innovative and efficient solutions for researchers and scientists, enabling them to prepare samples quickly and reliably.

The company's primary clients include academic institutions, pharmaceutical companies, and biotechnology firms. These clients use PreOmics' products for various applications such as research and discovery, characterization of biopharmaceuticals, bioanalysis, and targeted analysis. Notable clients include prestigious institutions like Harvard Medical School and UCSF, which rely on PreOmics' technology to stabilize technical variations and focus on biological research.

PreOmics' business model revolves around selling specialized kits and automated systems for sample preparation. Their product lineup includes the iST kit for protein and peptide preparation, the iST NHS kit for chemical labeling, the PHOENIX kit for peptide cleanup, and the PreON system for fully automated sample preparation. These products are designed to streamline the workflow, reduce preparation time, and increase the reliability of results.

The company generates revenue by selling these kits and systems directly to its clients. Additionally, PreOmics offers consultation services to help researchers address unique biological questions and concerns, further enhancing the value of their products.

In summary, PreOmics is revolutionizing the proteomics field with its innovative sample preparation solutions, catering to a diverse range of clients in academia and industry. By providing quick, reliable, and automated workflows, the company helps researchers achieve greater depth in their proteome analysis.

Keywords: Proteomics, Sample Preparation, LC-MS, Peptide, Protein, Biotechnology, Research, Automation, Biopharmaceuticals, Analysis.